BSE Live
Oct 14, 16:00Prev. Close
2441.80
Open Price
2440.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 14, 15:57Prev. Close
2442.50
Open Price
2436.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2438.10 (39)
Profit & Loss account of Mankind Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 9,497.80 | 9,263.66 | 8,120.57 | 7,240.86 | 5,486.16 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 9,497.80 | 9,263.66 | 8,120.57 | 7,240.86 | 5,486.16 | |
Total Operating Revenues | 9,497.80 | 9,264.81 | 8,127.15 | 7,257.04 | 5,529.60 | |
Other Income | 493.21 | 266.64 | 162.78 | 162.73 | 148.08 | |
Total Revenue | 9,991.01 | 9,531.45 | 8,289.94 | 7,419.77 | 5,677.68 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 800.43 | 861.74 | 711.05 | 772.24 | 494.53 | |
Purchase Of Stock-In Trade | 1,809.96 | 2,071.92 | 1,865.82 | 2,014.37 | 1,541.89 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -13.50 | -25.36 | 267.89 | -352.01 | -254.25 | |
Employee Benefit Expenses | 2,131.67 | 1,982.10 | 1,701.38 | 1,443.83 | 1,106.14 | |
Finance Costs | 371.76 | 14.57 | 27.75 | 43.83 | 7.98 | |
Depreciation And Amortisation Expenses | 378.01 | 317.61 | 269.58 | 120.98 | 78.19 | |
Other Expenses | 2,190.87 | 2,049.30 | 1,883.64 | 1,578.99 | 1,263.00 | |
Total Expenses | 7,685.02 | 7,271.88 | 6,727.10 | 5,622.23 | 4,237.47 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2,305.99 | 2,259.57 | 1,562.84 | 1,797.54 | 1,440.21 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 2,305.99 | 2,259.57 | 1,562.84 | 1,797.54 | 1,440.21 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 469.93 | 416.56 | 296.00 | 399.58 | 344.89 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -48.19 | 19.60 | 30.30 | 49.09 | 8.84 | |
Tax For Earlier Years | 0.00 | 0.00 | -11.72 | 13.74 | 2.10 | |
Total Tax Expenses | 421.74 | 436.16 | 314.58 | 462.41 | 355.83 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 1,884.25 | 1,823.41 | 1,248.26 | 1,335.13 | 1,084.37 | |
Profit/Loss From Continuing Operations | 1,884.25 | 1,823.41 | 1,248.26 | 1,335.13 | 1,084.37 | |
Profit/Loss For The Period | 1,945.48 | 1,823.41 | 1,248.26 | 1,335.13 | 1,084.37 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 48.16 | 45.52 | 31.16 | 33.33 | 27.07 | |
Diluted EPS (Rs.) | 48.07 | 45.45 | 31.16 | 33.33 | 27.07 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
13.10.2025
19.09.2025
11.09.2025
05.08.2025
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y
24.06.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y
22.05.2025
Mankind Pharma Consolidated March 2025 Net Sales at Rs 3,079.37 crore, up 26.15% Y-o-Y